Genetic Epidemiology, Translational Neurogenomics, Psychiatric Genetics and Statistical Genetics Laboratories investigate the pattern of disease in families, particularly identical and non-identical twins, to assess the relative importance of genes and environment in a variety of important health problems.
QIMR Home Page
GenEpi Home Page
About GenEpi
Publications
Contacts
Research
Staff Index
Collaborators
Software Tools
Computing Resources
Studies
Search
GenEpi Intranet
PMID
37164954
TITLE
Shared molecular genetic factors influence subcortical brain morphometry and Parkinson's disease risk.
ABSTRACT
Parkinson's disease (PD) is a late-onset and genetically complex neurodegenerative disorder. Here we sought to identify genes and molecular pathways underlying the associations between PD and the volume of ten brain structures measured through magnetic resonance imaging (MRI) scans. We leveraged genome-wide genetic data from several cohorts, including the International Parkinson's Disease Genomics Consortium (IPDG), the UK Biobank, the Adolescent Brain Cognitive Development (ABCD) study, the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE), the Enhancing Neuroimaging Genetics through Meta-Analyses (ENIGMA), and 23andMe. We observed significant positive genetic correlations between PD and intracranial and subcortical brain volumes. Genome-wide association studies (GWAS) - pairwise analyses identified 210 genomic segments with shared aetiology between PD and at least one of these brain structures. Pathway enrichment results highlight potential links with chronic inflammation, the hypothalamic-pituitary-adrenal pathway, mitophagy, disrupted vesicle-trafficking, calcium-dependent, and autophagic pathways. Investigations for putative causal genetic effects suggest that a larger putamen volume could influence PD risk, independently of the potential causal genetic effects of intracranial volume (ICV) on PD. Our findings suggest that genetic variants influencing larger intracranial and subcortical brain volumes, possibly during earlier stages of life, influence the risk of developing PD later in life.
© 2023. The Author(s).
DATE PUBLISHED
2023 May 10
HISTORY
PUBSTATUS PUBSTATUSDATE
received 2023/02/19
accepted 2023/04/28
medline 2023/05/11 00:42
pubmed 2023/05/11 00:41
entrez 2023/05/10 23:14
AUTHORS
NAME COLLECTIVENAME LASTNAME FORENAME INITIALS AFFILIATION AFFILIATIONINFO
García-Marín LM García-Marín Luis M LM Laboratorio Internacional de Investigación del Genoma Humano, Universidad Nacional Autónoma de México, Juriquilla, Querétaro, México. luis.garciamarin@qimrberghofer.edu.au.
Reyes-Pérez P Reyes-Pérez Paula P Laboratorio Internacional de Investigación del Genoma Humano, Universidad Nacional Autónoma de México, Juriquilla, Querétaro, México.
Diaz-Torres S Diaz-Torres Santiago S School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
Medina-Rivera A Medina-Rivera Alejandra A Laboratorio Internacional de Investigación del Genoma Humano, Universidad Nacional Autónoma de México, Juriquilla, Querétaro, México.
Martin NG Martin Nicholas G NG Mental Health and Neuroscience Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Mitchell BL Mitchell Brittany L BL School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
Rentería ME Rentería Miguel E ME School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
INVESTIGATORS
JOURNAL
VOLUME: 9
ISSUE: 1
TITLE: NPJ Parkinson's disease
ISOABBREVIATION: NPJ Parkinsons Dis
YEAR: 2023
MONTH: May
DAY: 10
MEDLINEDATE:
SEASON:
CITEDMEDIUM: Print
ISSN: 2373-8057
ISSNTYPE: Print
MEDLINE JOURNAL
MEDLINETA: NPJ Parkinsons Dis
COUNTRY: United States
ISSNLINKING: 2373-8057
NLMUNIQUEID: 101675390
PUBLICATION TYPE
PUBLICATIONTYPE TEXT
Journal Article
COMMENTS AND CORRECTIONS
GRANTS
GENERAL NOTE
KEYWORDS
MESH HEADINGS
SUPPLEMENTARY MESH
GENE SYMBOLS
CHEMICALS
OTHER ID's